Incremental Propensity Score Effects for Time-fixed Exposures.


Journal

Epidemiology (Cambridge, Mass.)
ISSN: 1531-5487
Titre abrégé: Epidemiology
Pays: United States
ID NLM: 9009644

Informations de publication

Date de publication:
01 03 2021
Historique:
pubmed: 21 1 2021
medline: 1 6 2021
entrez: 20 1 2021
Statut: ppublish

Résumé

When causal inference is of primary interest, a range of target parameters can be chosen to define the causal effect, such as average treatment effects (ATEs). However, ATEs may not always align with the research question at hand. Furthermore, the assumptions needed to interpret estimates as ATEs, such as exchangeability, consistency, and positivity, are often not met. Here, we present the incremental propensity score (PS) approach to quantify the effect of shifting each person's exposure propensity by some predetermined amount. Compared with the ATE, incremental PS may better reflect the impact of certain policy interventions and do not require that positivity hold. Using the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b), we quantified the relationship between total vegetable intake and the risk of preeclampsia and compared it to average treatment effect estimates. The ATE estimates suggested a reduction of between two and three preeclampsia cases per 100 pregnancies for consuming at least half a cup of vegetables per 1,000 kcal. However, positivity violations obfuscate the interpretation of these results. In contrast, shifting each woman's exposure propensity by odds ratios ranging from 0.20 to 5.0 yielded no difference in the risk of preeclampsia. Our analyses show the utility of the incremental PS effects in addressing public health questions with fewer assumptions.

Identifiants

pubmed: 33470712
doi: 10.1097/EDE.0000000000001315
pii: 00001648-202103000-00007
pmc: PMC9040452
mid: NIHMS1650139
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

202-208

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD102313
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063036
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063037
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063053
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD093602
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063046
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063072
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063048
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063047
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063041
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD063020
Pays : United States

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Curr Epidemiol Rep. 2020 Sep;7(3):125-131
pubmed: 33747714
Am J Epidemiol. 2021 Jul 15;:
pubmed: 34268558
Am J Obstet Gynecol. 2013 Dec;209(6):544.e1-544.e12
pubmed: 23973398
Biometrics. 2012 Jun;68(2):541-9
pubmed: 21977966
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Am J Epidemiol. 1986 Sep;124(3):453-69
pubmed: 3740045
Int J Epidemiol. 2017 Apr 1;46(2):756-762
pubmed: 28039382
Am J Clin Nutr. 2020 Jun 1;111(6):1235-1243
pubmed: 32108865
Epidemiology. 2009 Jan;20(1):3-5
pubmed: 19234395
Epidemiology. 2017 Jul;28(4):525-528
pubmed: 28282339
Am J Epidemiol. 2010 Oct 1;172(7):843-54
pubmed: 20716704
Ann Epidemiol. 2016 Oct;26(10):729-733
pubmed: 27659585
Eur J Epidemiol. 2018 May;33(5):459-464
pubmed: 29637384
Am J Obstet Gynecol. 2015 Apr;212(4):539.e1-539.e24
pubmed: 25648779
Stat Methods Med Res. 2012 Feb;21(1):31-54
pubmed: 21030422
Stat Med. 2013 Dec 30;32(30):5260-77
pubmed: 23913589
Epidemiology. 2009 Nov;20(6):880-3
pubmed: 19829187
J Acad Nutr Diet. 2013 Apr;113(4):569-80
pubmed: 23415502
Am J Epidemiol. 2014 Aug 15;180(4):436-45
pubmed: 25038216
Epidemiology. 2000 Sep;11(5):561-70
pubmed: 10955409

Auteurs

Ashley I Naimi (AI)

From the Department of Epidemiology, Emory University, Atlanta, GA.

Jacqueline E Rudolph (JE)

From the Department of Epidemiology, Emory University, Atlanta, GA.

Edward H Kennedy (EH)

Department of Statistics & Data Science, Carnegie Mellon University, Pittsburgh, PA.

Abigail Cartus (A)

Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA.

Sharon I Kirkpatrick (SI)

School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada.

David M Haas (DM)

Department of Obstetrics & Gynecology, School of Medicine, Indiana University, Indianapolis, IN.

Hyagriv Simhan (H)

Magee Womens Research Institute, University of Pittsburgh, Pittsburgh, PA.

Lisa M Bodnar (LM)

Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH